Correction to: Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression

Affiliations

• ¹ Department of Pathology, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
• ² Department of Breast Surgery, Institute of Breast Disease, The Second Hospital of Dalian Medical University, Dalian, Liaoning, People's Republic of China.
• ³ Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People's Republic of China.
• ⁴ Center of Pathology and Clinical Laboratory, Sir Run Run Hospital of Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
• ⁵ Department of Pathophysiology, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
• ⁶ Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, People's Republic of China. [email protected].
• ⁷ Department of Pathology, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China. [email protected].
• ⁸ Center of Pathology and Clinical Laboratory, Sir Run Run Hospital of Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China. [email protected].